Showing posts with label accuracy. Show all posts
Showing posts with label accuracy. Show all posts

Sunday, November 24, 2024

Critical process parameters of RMG ( RAPID MIXER GRANULATOR )

 In pharmaceutical manufacturing, particularly in the **Rapid Mixer Granulator (RMG)**, several **Critical Process Parameters (CPPs)** must be closely controlled to ensure the granulation process is consistent, reproducible, and results in a high-quality product. These parameters directly influence the granule properties such as size, density, and uniformity, which in turn affect the drug's dissolution, bioavailability, and stability.


### Key Critical Process Parameters (CPPs) in RMG:


1. **Impeller Speed (Mixing Speed)**:

   - **Impact**: The impeller speed determines the shear and intensity of the mixing action. Too low a speed may lead to inadequate mixing, while too high can result in excessive shearing and over-granulation, which can cause poor flowability and excessive fines.

   - **Control**: Typically adjusted based on the formulation requirements, with optimal speeds being set for different stages of granulation.


2. **Chopper Speed**:

   - **Impact**: The chopper assists in breaking down large agglomerates and controlling the granule size distribution. A high chopper speed may lead to smaller granules with improved uniformity but can generate excess heat, affecting sensitive APIs.

   - **Control**: Set based on the desired granule size and mixing characteristics.


3. **Binder Solution Addition Rate**:

   - **Impact**: The rate at which binder solution is added influences the granule porosity, size, and strength. Too rapid or too slow addition can result in uneven granulation, causing inconsistencies in final product quality.

   - **Control**: Controlled by the pump speed or manual addition, typically linked to the impeller speed.


4. **Binder Concentration**:

   - **Impact**: The concentration of the binder solution plays a critical role in the formation of granules. Higher binder concentration may lead to more robust granules, while lower concentration may result in poor binding and granulation.

   - **Control**: Optimized based on the formulation’s needs, especially for ensuring good tablet compaction and uniformity.


5. **Granulation Time**:

   - **Impact**: Granulation time influences the final granule size and uniformity. Too short a granulation time may lead to under-processed granules, while too long can result in over-granulation.

   - **Control**: Typically set based on the desired endpoint of granule formation, which is often indicated by granule consistency and uniformity.


6. **Granule Moisture Content**:

   - **Impact**: The moisture content of the granules directly affects their compressibility, flowability, and drying behavior. Too much moisture may cause clumping, while too little can result in poor granulation.

   - **Control**: Monitored by moisture sensors or checked periodically by sampling to adjust binder addition or granulation time.


7. **Temperature**:

   - **Impact**: Heat generated during the granulation process can affect the physical properties of the granules, especially if the formulation is sensitive to temperature. Excessive heat may cause degradation of the API.

   - **Control**: Temperature is controlled by adjusting the mixer speed, binder addition rate, and managing any external heating or cooling systems.


8. **Granule Size Distribution**:

   - **Impact**: The particle size distribution affects the flowability, compressibility, and uniformity of the powder for tableting. Narrow size distribution is often desirable for better tablet uniformity and content uniformity.

   - **Control**: Achieved by controlling the mixing speed, chopper speed, binder addition rate, and granulation time. Particle size can also be adjusted through sieve analysis or in-line size measurement techniques.


9. **Mixing Uniformity**:

   - **Impact**: Uniformity of mixing ensures that the API and excipients are evenly distributed within the granules. Poor mixing can lead to content uniformity problems and variations in drug release.

   - **Control**: Controlled by impeller speed, chopper speed, and the duration of mixing.


10. **End-Point Monitoring (Granulation Consistency)**:

   - **Impact**: The granulation process should be monitored for the endpoint, often determined by granule consistency (moisture content, size, and flow). Stopping the process too early or too late can affect granule quality.

   - **Control**: End-point monitoring is typically based on visual assessment, moisture sensors, or sampling for granule size and uniformity.


11. **Powder Flowability Before Granulation**:

   - **Impact**: The flow properties of the powder blend before granulation (such as bulk density and Carr’s index) affect the granulation process and the final granule quality. Poor flowability may result in inconsistent mixing or granule formation.

   - **Control**: Powder flowability can be improved with the proper selection of excipients, pre-mixing, or addition of flow agents.


### Additional Considerations:

- **Mixing Profile**: The mixing behavior (whether the granules exhibit uniformity or clumping) during the initial and final stages of granulation can also be critical. It may require careful monitoring and adjustments in speed or binder addition rates.

  

- **Process Scale-Up**: The control of these parameters becomes even more critical when scaling up from pilot to production batches, as slight changes in parameters can have a significant impact on the batch quality.


### Monitoring and Automation:

Many RMGs in modern pharmaceutical production are equipped with advanced process analytical technologies (PAT) to continuously monitor these critical parameters. These technologies provide real-time data and enable better control, thus reducing the risk of deviations and ensuring consistent product quality.


Effective control of these parameters ensures that the granulation process produces consistent, high-quality granules with the right properties for downstream processing (e.g., tableting or capsule filling), meeting regulatory and quality standards.

Sunday, August 6, 2023

What is change control ? Step by step handling of change control with examples ( Production department)

 In pharmaceutical production, change control is a crucial process that ensures any modifications to equipment, processes, or procedures are managed systematically and safely. Here are some examples of how change control is handled in the pharma industry:


Equipment Change: When a pharmaceutical company decides to replace or upgrade a critical manufacturing equipment, a formal change control process is initiated. It involves assessing the impact of the change, conducting risk assessments, and ensuring proper validation of the new equipment before implementation.


Process Change: If there is a need to modify a manufacturing process, change control is employed to evaluate the potential impact on product quality, safety, and efficacy. This process includes thorough documentation, testing, and validation to ensure the changes do not compromise product quality.


Raw Material Change: When there is a need to switch or modify a raw material used in drug manufacturing, change control is applied to evaluate the impact on the product's quality attributes and regulatory compliance. Any such change must be approved through a formal change control procedure.


Packaging Change: Pharmaceutical products are often subject to changes in packaging materials or design. Change control is employed to assess the impact on product stability, shelf life, and compatibility with the new packaging.


Change in Manufacturing Site: If a company decides to move production from one site to another, extensive change control measures are implemented to ensure the new facility meets regulatory requirements, maintains product quality, and prevents cross-contamination.


In all these examples, the change control process involves a thorough evaluation of potential risks, proper documentation, and adherence to regulatory guidelines to ensure patient safety and product quality are maintained throughout the changes.



The management of change control in pharmaceutical production involves a series of systematic steps to ensure that any modifications to equipment, processes, or procedures are evaluated, documented, and implemented in a controlled manner. Here are the typical steps in the change control process:


Initiation of Change Control Request: The process begins with the identification of a need for change, which could be due to various reasons such as process improvements, equipment upgrades, or regulatory requirements. The individual or department proposing the change initiates a change control request.


Change Proposal and Impact Assessment: A detailed change proposal is prepared, outlining the reasons for the change, its scope, and the intended benefits. An impact assessment is conducted to evaluate potential risks and impacts on product quality, safety, and regulatory compliance.


Change Control Review Board (CCRB): A Change Control Review Board or Committee, composed of cross-functional representatives, reviews the change proposal and impact assessment. The board ensures that all necessary aspects have been considered and evaluates the overall feasibility of the proposed change.


Approval and Authorization: If the Change Control Review Board approves the change, the proposal is formally authorized. The responsible personnel or department is assigned to implement and oversee the change.


Change Implementation Plan: A comprehensive implementation plan is developed, detailing the steps, resources, and timelines required to execute the change. This plan includes risk mitigation strategies and validation requirements.


Validation and Testing: Depending on the nature of the change, validation studies and testing may be conducted to ensure that the modified process or equipment functions as intended and meets the required quality standards.


Documentation and Records: Throughout the change control process, detailed documentation is maintained, including all change-related activities, decisions, and outcomes. This documentation is critical for regulatory compliance and audits.


Training and Communication: All relevant personnel are trained on the changes to ensure proper understanding and adherence to the new procedures. Effective communication is vital to keep all stakeholders informed during the implementation process.


Verification and Monitoring: After the change has been implemented, the process is monitored to ensure it performs as expected. This includes ongoing data collection and analysis to verify that the intended outcomes are achieved.


Closure and Review: Once the change is successfully implemented and verified, the change control process is formally closed. A post-implementation review is conducted to assess the effectiveness of the change and identify any lessons learned for future improvements.


By following these steps, pharmaceutical companies can effectively manage change control in production, ensuring product quality, safety, and compliance are maintained while facilitating continuous improvement in their operations.

Wednesday, July 26, 2023

Navigating the Changing Tides: Challenges and Strategies in the Indian Pharmaceutical Industry

Introduction


The Indian pharmaceutical industry has long been regarded as the "pharmacy of the world," supplying affordable generic medicines to millions globally. However, in recent times, it faces a host of challenges that necessitate innovative solutions to maintain its competitive edge. In this blog, we will explore some of the current challenges faced by the Indian pharmaceutical industry and propose effective strategies to overcome them.


Challenge 1: Changing Regulatory Landscape


One of the primary challenges the Indian pharmaceutical industry faces is the evolving regulatory environment both domestically and internationally. Stringent regulations in various countries, including the US and Europe, have necessitated compliance with stricter quality standards and documentation requirements.


Changing Regulatory Landscape


Strategy: Implementing Quality Management Systems


To overcome this challenge, pharmaceutical companies must invest in robust Quality Management Systems (QMS). This includes adopting Good Manufacturing Practices (GMP) and ensuring strict adherence to global regulatory guidelines. By establishing comprehensive QMS, companies can enhance their product quality, meet international standards, and expand their market reach.


Challenge 2: Rising Research and Development Costs


Developing new drugs and bringing them to market is an expensive and time-consuming process. The Indian pharmaceutical industry faces increasing pressure to invest heavily in research and development (R&D) to stay ahead in the innovation race.


Rising R&D Costs


Strategy: Collaborative R&D and Innovation Partnerships


To tackle the rising R&D costs, collaboration is key. Indian pharmaceutical companies can form partnerships with academic institutions, research organizations, and global pharmaceutical giants. Collaborative R&D efforts enable shared knowledge, resources, and risk, leading to faster drug development, reduced costs, and increased innovation potential.


Challenge 3 : Intellectual Property Rights (IPR) Concerns


The issue of intellectual property rights is another significant challenge for the Indian pharmaceutical industry. Generic drug manufacturers often face patent litigations from multinational pharmaceutical companies, affecting their ability to produce affordable medicines.


 Intellectual Property Rights


Strategy: Focus on Research and Manufacturing Process Improvements


To address IPR concerns, Indian pharmaceutical companies can concentrate on improving the manufacturing processes and formulation technologies. By developing novel drug delivery systems and manufacturing methods, they can offer differentiated products that are less susceptible to patent infringement claims.


Challenge 4: Pricing Pressures and Market Competition


The global pharmaceutical market is highly competitive, with price sensitivity becoming increasingly prominent. Indian pharmaceutical companies face constant pressure to maintain competitive pricing while ensuring quality standards.


4: Pricing Pressures


Strategy: Diversification and Market Expansion


To overcome pricing pressures, companies can focus on diversification and market expansion. Exploring new therapeutic areas, entering untapped markets, and leveraging digital health solutions can create new revenue streams and offset pricing challenges.


Conclusion


The Indian pharmaceutical industry has been a beacon of hope for affordable healthcare solutions worldwide. However, with changing times come new challenges that require innovative approaches. By addressing the regulatory landscape, investing in R&D collaborations, emphasizing process improvements, and diversifying their market reach, Indian pharmaceutical companies can rise above these challenges and continue to make a significant impact on global healthcare.


5: Future of Indian Pharma


As we move into the future, embracing technological advancements and fostering a culture of innovation will be crucial in maintaining the industry's growth trajectory. Together, by navigating these challenges, the Indian pharmaceutical industry can continue to be a driving force in providing accessible and affordable medicines for all.

Wednesday, June 15, 2022

Corrosion on tablet tooling its effect and remedies

Tablet tooling: Don’t let it corroded

Corrosion can severely affect tablet compression tooling if it is not addressed effectively. It can delay production, reduce efficiency and cause contamination problems.


Corrosion can be detected by the appearance of discoloration, etching or common red rust. The main cause of corrosion is acidic substances, which can include ingredients found within the formulation being compressed and even in the surrounding atmosphere. The iron particles in the metal tooling are exposed to oxygen and moisture in the form of humidity or vapor. When the steel is exposed to water, the iron particles are lost to the water’s acidic electrolytes. This means they oxidize the iron particles, which form corrosion on the punches and dies.


There are several reasons why corrosion can occur, and although challenging, it can be resolved with a combination of the correct steel, coating or treatment selection and proper maintenance procedures.



Atmospheric moisture

One of the principal causes of corrosion is excessive moisture and humidity. This is because corrosion often forms in areas where the liquid is present. Oxygen is found in the air we breathe and humid air carries water. The percentage of water vapor in the air varies based on temperature and can range from as low as 0.2% to up to 4% water vapor.


Excess humidity in the compression room, tool storage area or places where the drug formulation is stored prior to compaction can have a significant impact on corrosion forming on the tooling. It is therefore extremely important to control the environment in all areas of tablet production.


As we cannot remove oxygen from the air and tooling is made from steel, environmental factors should be in place to regulate the temperature and humidity and minimize moisture to prevent corrosion from forming on the punches and dies.





Formulation content

All formulations have very different characteristics with varying moisture content, which is often needed to help bind the tablet structure. However, too much water within the tablet can be a cause of corrosion and lead to other problems like sticking.


It is not just moisture content within the formulation that can lead to corrosion. Formulations containing corrosive elements such as chlorine, salts and acids will react with the tooling surfaces and result in oxidation. In addition, wash-in-place systems fitted to some modern tablet presses expose tooling to water and cleaning solutions. Post-compression cleaning procedures can also cause corrosion if not controlled appropriately. It is therefore important that tooling has the appropriate corrosion-resistant properties through the correct steel and coating selection.


Protecting against moisture

Optimizing the environment in which tablet compression and storage of tooling takes place can have a significant impact on preventing corrosion, but other solutions, including tooling material, coatings and maintenance, should also be considered.



Tool steel selection

Wear and degradation of tooling are inevitable in tablet manufacture. The repetitive cyclic action of compression will take its toll on tooling, particularly if they are not maintained. A substantial influence on tooling deterioration is the formulation being compressed. Some products can cause adverse effects on the punch tips — for example, certain granules are extremely hard and abrasive. These can scratch, wear and impregnate the steel surface. Other granulates can contain corrosive elements which react with the steel. This deterioration can lead to tableting defects like black spots, which are the result of corroded tooling and sticking where the granulation adheres to the punch tip face causing costly wastage, reduced yield and unwanted press downtime.

Although tools are manufactured from hardened and tempered tool steel, the demanding processes involved can lead to deterioration if the tool material is not optimized to suit the formulation being compressed.

High-quality tooling should be able to offer long life and be anti-abrasive and wear-resistant. The appropriate choice of material will help to reduce the risk of damage to the punches and dies from the effects of abrasion, corrosion and impregnation of hard granules.

The correct steel is crucial to the successful performance of tablet compression tooling. There are several characteristics that should be addressed when selecting steel:


Strength: Ability to withstand an applied stress without failure

Corrosion resistance: Resistance to oxidizing, staining and discoloration

Toughness: Resistance to chipping, cracking and punch tip breakage

Abrasive wear resistance: Resistance to abrasive wear of punch tips and die bores

Adhesive wear resistance: Resistance to adhesive wear, galling and welding

Hardness: Resistance to impregnation from hard, sharp granules

Compressive strength: Resistance to die bore ringing and plastic deformation of punch tip edges

Fatigue resistance: Progressive and localized structural damage that occurs when a material is subject to cyclic loading

If the tooling being used is prone to corrosion due to environmental effects or because of the characteristics of the formulation, a specially selected tool steel is a good option. Specialized martensitic stainless steels with high chromium content should be used as they have a higher resistance to oxidization, staining and discoloration of the tablet tooling.

Coatings and treatments

Tool coating selection can have a fundamental impact on production. When used in conjunction with high-quality tooling steel, tool coatings are a great method of solving tablet production problems. They allow for better tableting efficiency and output by reducing the requirement for tools to be taken out of production for additional cleaning and maintenance work to remove problematic residue, which, if left untreated, may cause potential production issues, such as corrosion, sticking and picking.


Traditionally, electro-plated hard chromium was the most popular coating used within the tablet tooling industry, but it has many disadvantages. When hard chromium is applied to tooling, a certain amount of hydrogen penetrates the substrate, which can decrease the steel’s working load by up to 20%. To counter this effect, the plated tools undergo a baking process known as de-embrittlement that reduces but does not eliminate the unwanted characteristic. It is also subject to micro-cracks which can develop during the plating process when the internal stress exceeds the tensile strength of the chromium. These micro-cracks are problematic because they provide a porous route to the substrate that will allow granule or cleaning solutions to attack the steel beneath.


Specialized coatings have been developed which are chromium-rich and applied via an advanced Physical Vapor Deposition (PVD) process. The PVD process creates a very smooth dense anti-stick coating. This process incurs none of the drawbacks associated with applying hard chrome.


When it comes to choosing a tool coating, understanding the product being compressed is crucial. For example, if the formulation has a high number of corrosive elements like salts and acids, it will eventually react with the steel and result in oxidation and other forms of decay. In these instances, an appropriate corrosion-resistant coating should be selected, for example, those containing chromium or chromium nitride.


Tool maintenance

Incorrect tool maintenance procedures including the handling, cleaning, polishing and storage of punches and dies can have a huge impact on tablet production. All these processes will expose the tooling to materials and environments where there is a risk of oxidization. It is therefore important that tried and tested maintenance practices are in place to prolong tool life.


The purpose of regular tablet tooling maintenance is simple: to minimize compression problems and ensure that it operates at its highest functionality. Ensuring tablet punches and dies are kept in optimum condition to produce high-quality tablets is critical for productivity and overall equipment effectiveness (OEE). Frequent audits of procedures should be planned to maintain and protect against corrosion issues. The cost of poor tool care and maintenance not only results in additional unnecessary tool purchases but also in production problems that could have been avoided.tooling is cleaned without corrosion inhibitor or insufficiently dried, corrosion can take place.

The appropriate cleaning procedures are essential when looking to prevent corrosion. It will remove granules from the punch and help to avoid product contamination and potential production issues such as sticking and picking caused by old products adhering to the surface of the punch tip.


Post-cleaning is also the ideal time to accurately assess the condition of the tooling. If punches are not clean, any visual assessment of the punch tips and die bores can be affected. This would mean that problems like wear, damage or corrosion are missed.


When tooling is removed from the tablet press, it must be thoroughly cleaned to remove any oil or product residue, particularly from difficult-to-reach areas such as embossing and keyways. One of the most reliable cleaning methods is ultrasonic cleaning. Ultrasonic baths allow for consistent cleaning results, reduced processing and operator time, and reduced risk of tablet contamination. Importantly, ultrasonic cleaning allows for the whole punch to be cleaned including in and around the embossing. It is essential, however, that the process does not cause corrosion of the tooling material, therefore a corrosion inhibitor should be added to the cleaning cycle at a defined concentration. This will form an oxide film on the surface of the metal, passivating the steel and protecting it from corrosion.


It is also important to remember to thoroughly dry tooling after cleaning to ensure there is no residue of cleaning fluids left on the tooling surface which could cause corrosion.


Appropriate storage is another critical process to consider when preventing corrosion. Tooling can be exposed to moisture if the storage system is not clean and dry. A good storage facility with tooling protected by a layer of non-toxic, FDA compliant oil or grease will help prevent corrosion from forming on the tooling surface. The duration of the tooling storage will determine if oil (short term) or grease (long term) is required.


Handling of the tooling can be another cause for concern. It is always recommended to use gloves when picking up the tooling. This is because acids and moisture are present in human hands and can cause and accelerate corrosion on tooling. It is not unheard of for a rusty fingerprint to be left behind! Ensuring gloves are worn at all times and following proper maintenance procedures and techniques will prevent this from happening.


Adopting a simple structured tooling maintenance process is essential to obtain the maximum life from punches and dies. By applying these recommended best practices problems like corrosion will be prevented and tool life will be extended.


Keep a check on corrosion


The cost of corrosion due to not understanding the characteristics of the formulation and poor tool care and storage not only results in additional unnecessary tool purchases but also in production problems that could have been avoided. It is important to address corrosion at the root cause so tablet production is not affected.

Know the granule being compressed, does it contain hard and abrasive granules or ingredients that contain chlorine, salts and acids? Is there high moisture content in the air where compression and storage take place? If the answer is ‘yes,’ it is important to protect tooling so corrosion does not take hold.

Through the use of the correct tool steel and corrosion-resistant coatings, the durability and efficiency of tablet tooling will increase. Add to this effective maintenance and tool care procedures and pharmaceutical manufacturers can obtain the maximum life from tablet punches and dies.


Friday, February 11, 2022

What is Data integrity and ALCOA plus in pharmaceutical industry

 What is Data Integrity?

Data integrity is the maintenance of, and the assurance of, data accuracy and consistency over its entire life-cycle and is a critical aspect to the design, implementation, and usage of any system that stores, processes, or retrieves data.

Data integrity is a key approach in the pharmaceutical quality control system. ALCOA is (Attributable, Legible, Contemporaneous, Original, and Accurate) was introduced in the 1990s for ensuring the pharma industry as a framework for data integrity and Good documentation practice (GDP). Then further introduced ALCOA plus is (Complete, Consistent, Enduring and Available) Currently used by the FDA, WHO, PIC/S, and GAMP. So overtime periods, data integrity concepts expand from ALCOA to ALCOA plus for ensuring data security and integrity ( data protection) are observed and maintained.


ALCOA+

ALCOA has five basic principles (Attributable, Legible, Contemporaneous, Original, and Accurate) to stop data integrity issues.





Attributable:

The collected data must be attributed, who performs the action and when, if a record is changed, who did it and why? For example, when during conducting of validation, the test result must be dated, and the initial should be done by the person involved in conducting the test. If any change in the monitoring system, the change detail should be in the audit trail and any correction made by the person should be recorded and dated. A signature log must be for the identification of initials and the person who completed the paper record.


Legible:

Legible data means the data can be easily read. This attribute should be ensured both in the short and long term, therefore the materials used in recording and collecting the data should be durable.

Contemporaneous:

The data should be recorded at the time and date of work performed. The timestamp should we follow in order.

For example, when conducting validation protocol, the result of the test performed should be recorded in an online sequence. Recording the results should be dated with a timestamp then logged in the electronic system.

Original:

The information must be recorded as original or in a certified true or original copy; this may be an acceptable protocol or a database or a notebook.

For example validation test is being recorded on a given protocol because recording test results in a Notebook may be a chance of error. If the original data is handwritten, it must be stored in an electronic system.

Accurate

For data and records to be accurate, they should be free from errors, complete, truthful and reflective of the observation. Editing should not be performed without documenting and annotating the amendments.

For example:

  • Use a witness check for critical record collection to confirm accuracy of data.
  • Consider how to capture data electronically and verify its accuracy. Build accuracy checks into the design of the electronic system.
  • Place controls/verification on manual data entry, for example, temperature results can only be entered within a predefined range of 0-100°C.

ALCOA PLUS (+)

Complete:- All data should be complete including, test repeat or re-analysis performed on the sample.

Consistent:-  Consistent in a generation of record and application of date and time stamps in the expected sequence.

Enduring:- Data should be recorded in a controlled worksheet in laboratory notebooks or invalidated Electronic systems.




Thursday, December 30, 2021

In process parameters during tablet/capsule/dry syrup manufacturing at Granulation stage

 Following parameters checked during granulation process 

1. Angle of repose- 

Angle of repose of any solid in pulverized form represent an angle measured in theta, 

Angle of repose = tan-¹(2h/d), unit is degree (°)

Acceptance =

 < 25° = Excellent 

25°-30°= Good

30°-40°= Average 

>40°= Bad 

2. LOD ( Loss on Drying ) 

Test is designed to measure the amount of water and volatile matters in a sample when the sample is dried under specified conditions eg. 100° C for 5 minutes 

Formula 

LOD = Initial weight before drying - final weight after drying / initial weight before drying ×100

3. Compressibility index 

Measure of the propensity of a powder to be Compressed also known as Carr's index 

Formula 

Carr's index = true density - bulk density / bulk density ×100

Acceptance 

<15% = Good flow 

>25% = Poor flow 

15%- 25% = Smooth for compression 

4. Bulk density and tap density 

Bulk density = density of powder in ML ( gm per ml )

Tap density = density of powder in ML after tapping at specified power in specified time.

Instrument used - sieve Shaker ( 20#, 40# ,60#)

eg. 

Blend weight = 50gm

Initial vol. of blend = 74ml 

After 500 tap blend = 64ml

After 750 tap blend = 64ml 

BD = 

50/74= 0.68%

TD=

50/64= 0.78%

Procedure for Calibration of Balances in pharmaceutical industry

 MONTHLY CALIBRATION OF BALANCES 

For monthly Calibration of Balances check following parameters-

1. Accuracy - verify the balance with minimum weight (least count × 100), 5%, 20%, 50%, 90% capacity of respective balance capacity.

Tolerance - the variation if any should be ± least count of the balance or ± 0.2% of certified standard weight used whichever is higher 

 2. Reproducibility - 

Check the reproducibility by using minimum standard weight of balance capacity. Place the weight in the middle of the weighing pan observe the displayed value 

Then calculate the %RSD by following formula 

RSD= SD×100 / X 

Where, 

X= mean of the individual value

Acceptance = %RSD should not be more than 2.0%

3. Eccentricity 

Eccentricity is the difference between the weight placed in centre and at peripheral points of the weighing pan 

CAPA in Pharmaceutical Industry – Complete Guide for Pharma Professionals

  ๐Ÿ”ท What is CAPA in Pharmaceutical Industry? CAPA (Corrective and Preventive Action) is a systematic approach used in the pharmaceutical in...